Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.
Physical activity and pediatric multiple sclerosis: Developing a research agenda.
Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation.
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
From precursors to myelinating oligodendrocytes: Contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain.
An adult case of multiphasic disseminated encephalomyelitis manifesting with optic neuritis.
Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
Use of an early disease-modifying drug adherence measure to predict future adherence in patients with multiple sclerosis.
The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient.
Efficacy and safety of alemtuzumab in multiple sclerosis and impact on nursing role.
Application of q-Space Diffusion MRI for the Visualization of White Matter.
Slowing of information processing speed without motor slowing in multiple sclerosis observed during two crossing-off tasks.
Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
Investigation-Directed Approach to Inflammatory Optic Neuropathies.
Computerised cognitive training in acquired brain injury: A systematic review of outcomes using the International Classification of Functioning (ICF).
Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients.
Electrophysiological Evaluation of Dysphagia in the Mild or Moderate Patients with Multiple Sclerosis: A Concept of Subclinical Dysphagia.
Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis.
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
Occurrence of CCSVI in patients with MS and its relationship with iron metabolism and varicose veins.
Rabies encephalomyelitis vs. ADEM: Usefulness of MR imaging in differential diagnosis.
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Pages
« first
‹ previous
…
554
555
556
557
558
559
560
561
562
…
next ›
last »